Fennec Pharmaceuticals Inc.FENCNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$26.98M
↑ 531% above average
Average (9y)
$-6.26M
Historical baseline
Range
High:$26.98M
Low:$-18.06M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $26.98M | +257.4% |
| 2023 | $-17.14M | +5.1% |
| 2022 | $-18.06M | -27.0% |
| 2021 | $-14.22M | +8.8% |
| 2020 | $-15.60M | -72.1% |
| 2019 | $-9.06M | -15.8% |
| 2018 | $-7.83M | -114.9% |
| 2017 | $-3.64M | -71.4% |
| 2016 | $-2.12M | -14.1% |
| 2015 | $-1.86M | - |